Bausch Health Cos Inc (NYSE: BHC) stock enjoyed a major increase of 12.6% on 10/31/24. The shares closed at $9.20. Moreover, exceptionally high trading volume at 333% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 14.0% during the last week.
Current PriceTarget Research Rating
BHC is expected to be an important Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Bausch Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment